Earnings Preview: Lumos Pharma
Portfolio Pulse from Benzinga Insights
Lumos Pharma (NASDAQ:LUMO) is scheduled to release its quarterly earnings report on March 7, 2024, with analysts expecting an EPS of $-1.15. The company's past performance shows a mixed reaction to earnings reports, with the stock price fluctuating based on actual EPS outcomes and guidance provided. Shares are currently trading at $3.05, down 17.16% over the last year, indicating a bearish sentiment among long-term shareholders.
March 06, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Lumos Pharma is expected to report an EPS of $-1.15 for the upcoming earnings, with historical data showing significant stock price movements post-earnings announcements.
Given Lumos Pharma's history of stock price volatility post-earnings, the upcoming report could lead to short-term price movements. However, the direction is uncertain as it heavily depends on whether the EPS beats or misses expectations and the nature of the guidance provided.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100